REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell death

Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1830-5. doi: 10.1161/01.ATV.0000142366.69080.c3. Epub 2004 Aug 12.

Abstract

Objective: Cholesterol accumulation in macrophages is known to alter macrophage biology. In this article we studied the impact of macrophage cholesterol loading on gene expression and identified a novel gene implicated in cell death.

Methods and results: The regulated in development and DNA damage response 2 (REDD2) gene was strongly upregulated as THP-1 macrophages are converted to foam cells. These results were confirmed by Northern blot of RNA from human monocyte-derived macrophages (HMDM) treated with oxidized LDL (oxLDL). Human REDD2 shares 86% amino acid sequence identity with murine RTP801-like protein, which is 33% identical to RTP801, a hypoxia-inducible factor 1-responsive gene involved in apoptosis. Treatment of HMDM with desferrioxamine, a molecule that mimics the effect of hypoxia, increased expression of REDD2 in a concentration-dependent fashion. Transfection of U-937 and HMEC cells with a REDD2 expression vector increased the sensitivity of the cells for oxLDL-induced cytotoxicity, by inducing a shift from apoptosis toward necrosis. In contrast, suppression of mRNA expression using siRNA approach resulted in increased resistance to oxLDL treatment.

Conclusions: We showed that stimulation of REDD2 expression in macrophages increases oxLDL-induced cell death, suggesting that REDD2 gene might play an important role in arterial pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Arteriosclerosis / genetics
  • Cell Death / physiology*
  • Cell Line
  • Cell Line, Tumor
  • Cells, Cultured
  • DNA / genetics
  • Deferoxamine / pharmacology
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / chemistry
  • Endothelium, Vascular / metabolism
  • Foam Cells / physiology
  • Humans
  • Hypoxia / pathology*
  • Lipoproteins, LDL / pharmacology*
  • Macrophages / drug effects*
  • Macrophages / physiology*
  • Monocytes / physiology
  • Proteins / physiology*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Transfection / methods
  • U937 Cells / chemistry
  • U937 Cells / metabolism
  • Up-Regulation / drug effects*
  • Up-Regulation / physiology*

Substances

  • Adaptor Proteins, Signal Transducing
  • DDIT4L protein, human
  • Lipoproteins, LDL
  • Proteins
  • RNA, Messenger
  • oxidized low density lipoprotein
  • DNA
  • Deferoxamine